The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.
FDA Approves Sarclisa for Certain Patients with Multiple Myeloma
The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.
